共 50 条
- [3] Opportunities for Trisenox® (arsenic trioxide) in the treatment of myelodysplastic syndromes Leukemia, 2003, 17 : 1499 - 1507
- [6] New data with arsenic trioxide in leukemias and myelodysplastic syndromes CLINICAL LYMPHOMA & MYELOMA, 2007, 8 : S7 - S12
- [10] Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study Journal of Hematology & Oncology, 5